Nippon Soda Co., Ltd. manufactures and markets a diverse portfolio of chemical products, encompassing agri-business offerings such as fungicides including thiophanate-methyl, insecticides, acaricides, herbicides, and industrial fungicides; pharmaceuticals comprising active pharmaceutical ingredients, intermediates, and excipients like hydroxypropyl cellulose (NISSO HPC); specialty chemicals leveraging proprietary technologies for high-value applications in electronics and industrial materials; eco chemicals supporting environmental protection, safety, and health; and chlor-alkali products including caustic soda and related basic industrial chemicals.
The company operates through segments including chemicals, agro products, trading, transportation and warehousing, construction, and others, serving global markets with an overseas sales ratio of approximately 50% as of fiscal year 2025; it maintains key production facilities such as the Nihongi Plant in Niigata Prefecture, Takaoka Plant in Toyama Prefecture, and Chiba Plant.
Founded in 1920 and headquartered at JP Tower in Chiyoda-ku, Tokyo, Japan, Nippon Soda focuses on agriculture, healthcare, environment, and ICT sectors to create societal value through chemistry under its long-term vision "Brilliant Through Chemistry 2030."
In recent developments, the company formed a capital and business alliance with Kyulux Inc. in October 2024 to develop mass production systems for thermally activated delayed fluorescence (TADF) materials for OLED displays, building on their joint development agreement since 2020; additionally, in August 2025, it entered a joint research and development agreement with KAICO Ltd. for veterinary pharmaceuticals.